Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The B7:CD28 family and friends: Unraveling coinhibitory interactions
Kelly P. Burke, Apoorvi Chaudhri, Gordon J. Freeman, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 223-244
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy
Qiang Liu, Yujing Guan, Shenglong Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Cross-priming in cancer immunology and immunotherapy
Carlos Luri‐Rey, Álvaro Teijeira, Stefanie K. Wculek, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 3
CD28 co-stimulation: novel insights and applications in cancer immunotherapy
Michael T. Lotze, Scott H. Olejniczak, Dimitris Skokos
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 878-895
Closed Access | Times Cited: 15
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Directed Evolution of Multicyclic Peptides Using Yeast Display for Sensitive and Selective Fluorescent Analysis of CD28 on the Cell Surface
Chaoying Xu, Xiaoting Meng, Ping Chai, et al.
Analytical Chemistry (2025)
Closed Access | Times Cited: 1
Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives
Zhiyi Ye, Pu Cheng, Qi Huang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Programmed cell death-ligand 2: new insights in cancer
Yukang Yang, Yan Xia, Xueqi Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Emerging roles of checkpoint molecules on B cells
Hiromitsu Asashima, Satoshi Akao, Isao Matsumoto
Immunological Medicine (2025), pp. 1-12
Open Access
PD-L1-CD80 interactions are required for intracellular signaling necessary for dendritic cell migration
Uma Kantheti, Tadg Forward, Erin D. Lucas, et al.
Science Advances (2025) Vol. 11, Iss. 5
Closed Access
CD8+CD28+PD1− T Cells as a Prognostic Biomarker in Endometrial Cancer
Yufei Nie, Lin Yang, Yanan Zhang, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 121-121
Open Access
The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes
Tongguo Shi, Huan Zhang, Yueqiu Chen
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors
Fei Du, Guojun Wang, Qian Dai, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Resistance to PD-1/PD-L1 immune checkpoint blockade in advanced non-small cell lung cancer
Lijun Li, Haihong Pu, Xiaoxin Zhang, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 209, pp. 104683-104683
Closed Access
Humanizing a CD28 signaling domain affects CD8 activation, exhaustion and stem-like precursors
Alexander Brady, Shankar Revu, Dongwen Wu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Unusual traits shape the architecture of the Ig ancestor molecule
Alejandro Urdiciain, Thomas Madej, Jiyao Wang, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
T cell aging and exhaustion: Mechanisms and clinical implications
Weiqi Zhang, Dejun Kong, Xiaohan Zhang, et al.
Clinical Immunology (2025) Vol. 275, pp. 110486-110486
Closed Access
The Structural Biology of T‐Cell Antigen Detection at Close Contacts
Yuan Lui, João Ferreira Fernandes, Mai Tuyet Vuong, et al.
Immunological Reviews (2025) Vol. 331, Iss. 1
Open Access
CD86 is linked to apoptosis in canine histiocytic sarcoma
Benjamin Diehl, Agnes Kirchhoff, Florian Hansmann
Frontiers in Veterinary Science (2025) Vol. 12
Open Access
Induction and Assessment of Activation in Rat Effector CD4+ Memory Th Cells
Lukas C. Müller-Kirschbaum, Dmitri Lodygin, Francesca Odoardi, et al.
Methods in molecular biology (2025), pp. 145-158
Closed Access
Efficacy and safety of anti-PD-1 versus anti-PD-L1 in perioperative immunotherapy: A comprehensive reanalysis of randomized controlled trials
Chaoqi Zhang, Peng Wu, Dongyu Li, et al.
Med (2025), pp. 100669-100669
Closed Access
Immunological Disorders: Gradations and the Current Approach in Laboratory Diagnostics
Анна Старшинова, А. А. Савченко, А. Г. Борисов, et al.
Pathophysiology (2025) Vol. 32, Iss. 2, pp. 17-17
Open Access
CD8+ T-cell exhaustion: Impediment to triple-negative breast cancer (TNBC) immunotherapy
Dandan Feng, Dongqing Pu, Juan Ren, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189193-189193
Closed Access | Times Cited: 3
Unusual traits shape the architecture of the Ig ancestor molecule
Alejandro Urdiciain, Thomas Madej, Jiyao Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1
Zhen Yang, Xinpeng Liu, Jun Zhu, et al.
Cancer Cell (2024) Vol. 43, Iss. 1, pp. 86-102.e10
Closed Access | Times Cited: 2
Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinoma
Wenjing Li, Jianqing You, Haixiang Xue, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 10
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top